Cueto, Calixto M.

HRN: 14-52-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CIPROFLOXACIN 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
BID
E. Histolytica
Waiting Final Action 
04/29/2022
METRONIDAZOLE 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
Tid
E. Histolytica
Waiting Final Action 
09/23/2022
CIPROFLOXACIN 500MG (TAB)
09/23/2022
09/29/2022
PO
500 Mg
Bid
Uti
Waiting Final Action 
09/23/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/23/2022
09/29/2022
IV
500 Mg
Q 8 Hrs
Amebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: